<DOC>
	<DOCNO>NCT00281255</DOCNO>
	<brief_summary>This study determine whether acute infusion intravenous allopurinol improve inotropic response dobutamine patient idiopathic dilate cardiomyopathy ( DCM ) measure cardiac magnetic resonance imaging ( CMR ) .</brief_summary>
	<brief_title>Intravenous Allopurinol Improve Heart Function Individuals With Dilated Cardiomyopathy</brief_title>
	<detailed_description>BACKGROUND : DCM poorly understand cause systolic heart failure common indication heart transplantation United States . Despite advance medical device therapy , 5-year mortality patient DCM remain near 50 % . Oxidative stress , imbalance formation degradation free radical within myocardium , contribute metabolic derangement patient DCM . The enzyme xanthine oxidase ( XO ) , potent source oxidative stress , express failing heart , uncouples cardiac energy consumption cardiac contraction set chronic heart failure . These effect reverse inhibit XO XO inhibitor allopurinol , result marked increase cardiac efficiency . These finding provide rationale use allopurinol enhance cardiac function DCM . However , little data effect allopurinol therapy cardiac function . Therefore , primary aim study determine whether acute infusion intravenous allopurinol improve inotropic response beta-adrenergic stimulation patient idiopathic DCM . Decreased beta-adrenergic responsiveness characteristic feature DCM attributable part decrease expression beta 1-receptor chronic heart failure , well dysregulation down-stream signal pathway . Improvement beta-adrenergic responsiveness useful surrogate marker long-term improvement cardiac structure , function , decreased cardiac event . Traditionally , invasive hemodynamic monitoring use pressure pressure/volume catheter method choice quantify inotropic response heart failure . However , newly develop magnetic resonance imaging ( MRI ) techniques allow precise assessment inotropic response non-invasively . Studies show tag CMR reproducible , noninvasive method quantify inotropic response beta 1 agonist dobutamine individual structurally normal heart . Specifically , radial strain ( E1 ) circumferential strain ( E2 ) measure increase dos dobutamine use tag CMR . Changes strain parameter , refer delta E1 delta E2 , precise measurement beta-inotropic response . DESIGN NARRATIVE : An estimated 20 patient DCM randomize 1:1 ratio fashion receive allopurinol placebo . The primary aim investigation determine whether acute infusion intravenous allopurinol improve inotropic response dobutamine patient idiopathic DCM measure CMR . Specifically , study test hypothesis single dose intravenous allopurinol , compare placebo , enhance delta E1 delta E2 . Secondary aim study follow : 1 ) determine whether response allopurinol associate baseline XO activity level natriuretic peptide ( investigator predict augmentation delta E1 delta E2 correlate positively baseline plasma uric acid plasma B-type natriuretic peptide [ BNP ] ) ; 2 ) demonstrate tag dobutamine CMR useful non-invasive technique ass pharmacologic response patient heart failure .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>Diagnosis idiopathic cardiomyopathy ( define ejection fraction less equal 35 % assessed method within 6 month prior study entry AND evidence coronary artery disease , determine coronary angiography stress perfusion image within 2 year prior study entry ) New York Heart Association ( NYHA ) Class I II heart failure Stable heart failure medication least 1 month prior study entry Able lie flat 45 minute History poorly control hypertension concentric leave ventricular hypertrophy echocardiography suggest hypertensive cardiomyopathy History biopsyproven myocarditis Peripartum cardiomyopathy Allopurinol therapy within 6 month prior study entry Allopurinol allergy Contraindication allopurinol concomitant therapy one following : azathioprine , cyclophosphamide , dicumarol , uricosuric agent ( e.g. , probenecid ) , ampicillin , amoxicillin , chlorpropamide , cyclosporine Acute gout Estimated creatinine clearance le 20 ml/min Total bilirubin great 2 time upper limit normal Serum aspartate AST alanine ALT great 3 time upper limit normal White blood cell count le 2,000 Platelet count le 80,000 Hemoglobin less 8 mg/dl Use intravenous inotropes History untreated symptomatic ventricular tachycardia History sustain ventricular tachycardia induce dobutamine Contraindication MRI one following : 1 . StarrEdwards pre6000 series prosthetic valve prosthetic valve model determine 2 . Implanted pacemaker 3 . Implanted cardioverterdefibrillator intracranial aneurysm clip 4 . Other implant medical device know MRI incompatible ( e.g. , cochlear implant spinal stimulators ) 5 . History foundrywork could create ocular metallic fragment Hospitalization least 1 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>